CMPX Q2 2023 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CMPXCompass Therapeutics, Inc.

$781M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$13M

Net Income

-$11M

EPS (Diluted)

$-0.09

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$179M

Total Liabilities

$11M

Stockholders' Equity

$168M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$13M	-$9M	-48.4%
Net Income	-$11M	-$8M	-32.8%